These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 3381299)

  • 1. Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporine.
    Ludwin D; Bennett KJ; Grace EM; Buchanan WW; Bensen W; Bombardier C; Tugwell PX
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):367-70. PubMed ID: 3381299
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine: therapeutic effects in rheumatic diseases.
    Amor B; Dougados M
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):218-23. PubMed ID: 3289207
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine A in rheumatoid arthritis: results at 30 months.
    Madhok R; Capell HA
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):248-52. PubMed ID: 3132774
    [No Abstract]   [Full Text] [Related]  

  • 4. Low dose cyclosporine in rheumatoid arthritis: a pilot study.
    Tugwell P; Bombardier C; Gent M; Bennett K; Ludwin D; Grace E; Buchanan WW; Bensen WG; Bellamy N; Murphy GF
    J Rheumatol; 1987 Dec; 14(6):1108-14. PubMed ID: 3437417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of non-steroidal anti-inflammatory agents on kidney function in patients with rheumatoid arthritis].
    Dvorkin EB; Murav'ev IuV
    Revmatologiia (Mosk); 1991; (2):28-30. PubMed ID: 1925261
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible nephrotoxicity of cyclosporine in rheumatoid arthritis.
    Boers M; Dijkmans BA; van Rijthoven AW; Goei Thè HS; Cats A
    J Rheumatol; 1990 Jan; 17(1):38-42. PubMed ID: 2179550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening patients on long term non-steroidal anti-inflammatory drugs (NSAIDs) for nephrotoxicity--why necessary and how frequently?
    Chogle AR
    J Assoc Physicians India; 2003 Nov; 51():1041-2. PubMed ID: 15260384
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal function in patients with autoimmune diseases treated with cyclosporine.
    von Graffenried B; Harrison WB
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):215-31. PubMed ID: 3839609
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of rheumatoid arthritis with low-dose cyclosporine A.
    Yoshinoya S; Yamamoto K; Mitamura T; Aikawa T; Takeuchi A; Takahashi K; Miyamoto T
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):243-7. PubMed ID: 3381277
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
    Feutren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):356-66. PubMed ID: 3381298
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients.
    Berg KJ; Nordby G; Rootwelt K; Djøseland O; Fauchald P; Mehl A; Narverud J; Talseth T
    Transplant Proc; 1988 Jun; 20(3):413-5. PubMed ID: 3289171
    [No Abstract]   [Full Text] [Related]  

  • 12. Longterm cyclosporine therapy in rheumatoid arthritis.
    van Rijthoven AW; Dijkmans BA; Goei Thè HS; Boers M; Cats A
    J Rheumatol; 1991 Jan; 18(1):19-23. PubMed ID: 2023194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-induced renal disorders in patients with rheumatoid arthritis].
    Nakano M; Nishi S; Ueno M; Saito T; Hasegawa H; Arakawa M
    Ryumachi; 1996 Oct; 36(5):775-82. PubMed ID: 8969558
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum creatinine levels two years later: follow-up of a placebo-controlled trial of cyclosporine in rheumatoid patients.
    Boers M; van Rijthoven AW; Goei Thè HS; Dijkmans BA; Cats A
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):371-5. PubMed ID: 3289212
    [No Abstract]   [Full Text] [Related]  

  • 16. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
    Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665
    [No Abstract]   [Full Text] [Related]  

  • 17. [A long-term evaluation of CN-100 in patients with rheumatoid arthritis].
    Komatsubara Y; Azuma T
    Ryumachi; 1991 Apr; 31(2):230-46. PubMed ID: 1925803
    [No Abstract]   [Full Text] [Related]  

  • 18. [4-prenyl-1,2-diphenyl-3,5-pyrazolidindione (DA 2370) in rheumatoid arthritis: clinical study with the use of a new weighted articular index].
    Cerri B; Bianchi G; Chierichetti S
    Reumatismo; 1972; 24(3):217-24. PubMed ID: 4549698
    [No Abstract]   [Full Text] [Related]  

  • 19. The place of cyclosporine A in the treatment of connective tissue diseases.
    Miescher PA; Favre H; Mihatsch MJ; Chatelanat F; Huang YP; Zubler R
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):224-37. PubMed ID: 3381275
    [No Abstract]   [Full Text] [Related]  

  • 20. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.